AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients
Clinical trial NCT04513951 · COMPLETED
Trial details
- NCT number
- NCT04513951
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2023-06-28
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.